ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 298

$498K Total Retail Price of All Prescriptions

Rank: 33 out of 298

477 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,466 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 350 190 1 3
TRAMADOL HCL 238 158 2 15
FUROSEMIDE 224 177 3 5
AMLODIPINE BESYLATE 210 184 4 6
SIMVASTATIN 199 169 5 2
CITALOPRAM HBR 192 143 6 17
HYDROCODONE-ACETAMINOPHEN 184 94 S3 7 8
LISINOPRIL 182 140 8 4
LEVOTHYROXINE SODIUM 169 140 9 1
WARFARIN SODIUM 167 156 10 7
POTASSIUM CHLORIDE 166 139 11 11
METFORMIN HCL 160 103 12 10
LOSARTAN POTASSIUM 151 138 13 18
TAMSULOSIN HCL 147 133 14 24
HYDROCHLOROTHIAZIDE 146 104 15 13
METOPROLOL SUCCINATE 140 128 16 12
CARVEDILOL 132 110 17 23
PRAVASTATIN SODIUM 128 84 18 31
KLOR-CON 10 120 62 19 61
ENALAPRIL MALEATE 116 87 20 58
SERTRALINE HCL 99 75 21 19
METOCLOPRAMIDE HCL 92 40 22 103
ATORVASTATIN CALCIUM 78 78 23 14
TRAZODONE HCL 77 39 24 39
DIOVAN 72 72 25 47
QUINAPRIL HCL 72 65 25 109
GABAPENTIN 72 37 25 20
ZOLPIDEM TARTRATE 71 62 28 25
EVISTA 70 39 29 134
SPIRIVA 69 43 30 55
CRESTOR 68 38 31 26
DIGOXIN 66 65 32 27
LOSARTAN-HYDROCHLOROTHIAZIDE 65 60 33 44
ATENOLOL 64 57 34 16
PREDNISONE 63 58 35 33
JANUVIA 63 57 35 73
NEXIUM 61 23 37 40
BACLOFEN 60 14 38 97
ALLOPURINOL 60 60 38 28
PRAMIPEXOLE DIHYDROCHLORIDE 59 42 40 114
SPIRONOLACTONE 57 49 41 34
GEMFIBROZIL 55 40 42 65
LACTULOSE 55 14 42 120
FLUTICASONE PROPIONATE 54 38 44 38
FAMOTIDINE 53 30 45 80
CYCLOBENZAPRINE HCL 52 36 R 46 100
OXYCODONE HCL 52 24 S2 46 79
LOVASTATIN 50 50 48 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.